ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting (P7-1.014)

20251 citationsJournal Article

Authors

To evaluate the real-world clinical effectiveness, safety, and tolerability of ublituximab.

Published in: Neurology

Volume 104, Issue 7_Supplement_1

Field-Weighted Citation Impact: 1.06